| Style | Citing Format |
|---|---|
| MLA | Hooshyarazar E, et al.. "Acupuncture in Uterine Fibroids Management: Literature Update on Frequently Used Acupoints and the Underlying Mechanism—A Narrative Review." Health Science Reports, vol. 8, no. 12, 2025, pp. -. |
| APA | Hooshyarazar E, Azizi H, Layegh P, Dadgarmoghaddam M, Kazemi AH, Farahmand SK, Hafizi L (2025). Acupuncture in Uterine Fibroids Management: Literature Update on Frequently Used Acupoints and the Underlying Mechanism—A Narrative Review. Health Science Reports, 8(12), -. |
| Chicago | Hooshyarazar E, Azizi H, Layegh P, Dadgarmoghaddam M, Kazemi AH, Farahmand SK, Hafizi L. "Acupuncture in Uterine Fibroids Management: Literature Update on Frequently Used Acupoints and the Underlying Mechanism—A Narrative Review." Health Science Reports 8, no. 12 (2025): -. |
| Harvard | Hooshyarazar E et al. (2025) 'Acupuncture in Uterine Fibroids Management: Literature Update on Frequently Used Acupoints and the Underlying Mechanism—A Narrative Review', Health Science Reports, 8(12), pp. -. |
| Vancouver | Hooshyarazar E, Azizi H, Layegh P, Dadgarmoghaddam M, Kazemi AH, Farahmand SK, et al.. Acupuncture in Uterine Fibroids Management: Literature Update on Frequently Used Acupoints and the Underlying Mechanism—A Narrative Review. Health Science Reports. 2025;8(12):-. |
| BibTex | @article{ author = {Hooshyarazar E and Azizi H and Layegh P and Dadgarmoghaddam M and Kazemi AH and Farahmand SK and Hafizi L}, title = {Acupuncture in Uterine Fibroids Management: Literature Update on Frequently Used Acupoints and the Underlying Mechanism—A Narrative Review}, journal = {Health Science Reports}, volume = {8}, number = {12}, pages = {-}, year = {2025} } |
| RIS | TY - JOUR AU - Hooshyarazar E AU - Azizi H AU - Layegh P AU - Dadgarmoghaddam M AU - Kazemi AH AU - Farahmand SK AU - Hafizi L TI - Acupuncture in Uterine Fibroids Management: Literature Update on Frequently Used Acupoints and the Underlying Mechanism—A Narrative Review JO - Health Science Reports VL - 8 IS - 12 SP - EP - PY - 2025 ER - |